Special Announcement: PRAXIS CEO
The PRAXIS Australia Ltd Board today announced that Melanie Gentgall will step down from her role as founding CEO in late October, 2021.
PRAXIS Chair, Terry McGuirk stated “over the last 7 years, Melanie has played a pivotal role in shaping PRAXIS Australia into the organisation you see today. Melanie’s ability to foster relationships, her comprehensive knowledge of the sector and an understanding of the educational needs of all individuals across the ecosystems in which we operate have been critically important to the success of PRAXIS. Her dedication, energy and enthusiasm has known no bounds.
The Board and I thank Melanie for her considerable contributions and are delighted for her as she embarks on a new and exciting career challenge, that will harness her diverse skill set and capabilities.
We wish her every success and happiness and welcome Melanie’s ongoing involvement in PRAXIS Australia into the future.”
The Board of PRAXIS Australia would also like to congratulate Sally Armstrong who has been appointed as Melanie’s successor. They look forward to working with Sally as she transitions into the role over coming months to help shape the future of the Company and continue it’s important contribution to Australia’s research education environment.
#PraxisAus #ClinicalTrials #ClinicalResearch #FromComplianceToExcellence #CEO